Annual Report 2019: State of the Bio Industry
This annual compilation reviews new developments, trends and outlooks in areas such as biotechnology, biosimilars, biopharmaceuticals, biologics, biomarkers and biosimulation.
Featured Posts
2019 Annual Report: Healthcare Communications Agencies Overview – Another Year Of Changes, Growth
The healthcare ad industry continues to thrive and adapt to the new demands for relevance and creativity.
Top 10 Pipelines To Watch: 2019 Annual Report
The return on R&D investment for leading biopharmaceutical manufacturers fell to a nine-year low while the U.S. FDA approved a record-breaking amount of novel medicines during 2018.
PulseCX: 2019
PulseCX is a full-service, independent, mid-sized healthcare marketing agency located just outside Philadelphia. PulseCX specializes in optimizing the customer experience (CX) for pharmaceutical brands, medical devices, and OTC products.
2019 Annual Report: Healthcare Communications Agencies Overview – Another Year Of Changes, Growth
The healthcare ad industry continues to thrive and adapt to the new demands for relevance and creativity.
Top 10 Pipelines To Watch: 2019 Annual Report
The return on R&D investment for leading biopharmaceutical manufacturers fell to a nine-year low while the U.S. FDA approved a record-breaking amount of novel medicines during 2018.
Healthcare Agency Roundtable 2018
Leadership representing the 2018 Manny Award agency and network winners and finalists share their views on various healthcare industry trends and developments.
2018 Annual Report: Top 50 Companies – Looking to future challenges
The top pharmaceutical companies are trying to proactively tackle, through shifts in R&D strategy and other tactics, the healthcare demands of the future.
Company of the Year 2018 — Johnson & Johnson: Defining the future of healthcare
The executive management team of this “132-year-old startup” company is excited about a future that lies beyond the intersection of science and technology.
Top 200 Medicines Annual Report 2018: Blockbusters thriving despite tumultuous climate
There were as many billion-dollar brands in 2017 as there have been in any other calendar year despite the cratering effects of massive patent cliffs in 2012 and 2015.
Annual Report 2018: State of the Bio Industry
This yearly review analyzes recent developments, trends and outlooks in the areas of biotechnology, biosimilars, biopharmaceuticals, biologics, biomarkers and biobanks.
2018 Annual Report: Healthcare Communications Agencies Overview – A Year Of Steady Successes
2017 was a very good year for many of the agencies profiled in this annual directory featuring the leading healthcare communications agencies. Some reported individual setbacks, but they were still able to overcome these. As a wave of new drugs and biologics hit the market, several of the top healthcare agencies supported their launches.
Ad Right Top
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com. 
June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!